PROCYSTEINE TM TO PLACEBO IN HIV INFECTED PTS TAKING ANTIRETROVIRAL NUCLEOSIDE

PROCYSTEINE TM 与服用抗逆转录病毒核苷的 HIV 感染患者的安慰剂

• 批准号: 3763392
• 负责人: MICHAEL M LEDERMAN
• 金额: --
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3763392
• 关键词: 2'3' dideoxycytidine; 2'3' dideoxyinosine; AIDS; AIDS therapy; HIV infections; antiAIDS agent; antiviral agents; clinical trials; combination therapy; drug screening /evaluation; human subject; human therapy evaluation; oral administration; placebos; zidovudine

To compare the efficacy and safety of orally administered Procysteine TM with placebo in HIV-infected patients who are receiving AZT, DDI, AZT & DDI, or AZT & DDC. This was a double-blind randomized study conducted at eight sites and is now closed.

比较口服半胱氨酸的有效性和安全性 TM与安慰剂在接受AZT、DDI、 AZT和DDI，或AZT和DDC。 这是一项双盲随机研究 在8个地点进行， 现已关闭。